From a technical view, the ETF has pushed below a rising trend line which has been in place since February 2013. Regarding technical indicators, the daily RSI has broken below a key support area and the 20-day moving average is turning down providing another argument for a consolidation in coming days. On a relative basis against the IVV S&P500, the iShares Nasdaq Biotechnology Index Fund has broken below a bullish trend line and looks set for a consolidation. Trading strategy: Short Sell at $178.24 - Stop loss at $187.05 - Target at $157.50.